STEWART KENT D.,WALLACE GRIER A.,ARGIRIADI MARIA A.,WOLLER KEVIN R.,WISHART NEIL,FIAMENGO BRYAN A.,WANG LU,ERICSSON ANNA M.,MORYTKO MICHAEL J.,FRIEDMAN MICHAEL,VOSS JEFFREY W.,GEORGE DAWN M.,CALDERWOO
申请号：
NZ60016110
公开号：
NZ600161A
申请日:
2010.12.01
申请国别(地区):
NZ
年份:
2014
代理人:
摘要：
The disclosure provides compounds of Formula (I) and Formula (II), pharmaceutically acceptable salts, pro-drugs, biologically active metabolites, stereoisomers and isomers thereof wherein the variable are defined herein. The compounds of the disclosure are useful for treating immunological and oncological conditions. In one embodiment the compound is 3-((3S,4S)-3-(3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazin-8-yl)-4-methylpiperidin-1-yl)-3-oxopropanenitrile.
